Shares of Vertex Pharmaceuticals surged more than 26 percent at the open of trading Wednesday, as the drugmaker crushed Wall Street's expectations when it reported an improved response in patients suffering from cystic fibrosis. The biotech told CNBC on Tuesday that its three-drug cocktails boosted a measure of lung function in patients with cystic...